Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma

Abstract Pulmonary Sarcomatoid Carcinoma (PSC) constitutes a heterogeneous group of non-small-cell lung carcinomas (NSCLCs) with a poor prognosis. In this study, a group of 7 patients with PSC was studied. Microscope analysis of all 7 cases revealed a pleomorphic carcinoma subtype. Moreover, 5 cases...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xin Li, Dan Wang, Qingchun Zhao, Dian Ren, Fan Ren, Gang Chen, Hongyu Liu, Jun Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7f255ce762154ad9ae0a37828e1def78
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7f255ce762154ad9ae0a37828e1def78
record_format dspace
spelling oai:doaj.org-article:7f255ce762154ad9ae0a37828e1def782021-12-02T15:05:10ZClinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma10.1038/s41598-017-04296-22045-2322https://doaj.org/article/7f255ce762154ad9ae0a37828e1def782017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04296-2https://doaj.org/toc/2045-2322Abstract Pulmonary Sarcomatoid Carcinoma (PSC) constitutes a heterogeneous group of non-small-cell lung carcinomas (NSCLCs) with a poor prognosis. In this study, a group of 7 patients with PSC was studied. Microscope analysis of all 7 cases revealed a pleomorphic carcinoma subtype. Moreover, 5 cases (71.4%) were composed entirely of malignant sarcomatoid-like elements, and 2 cases (28.6%) were composed of malignant sarcomatoid-like elements and at least 10% adenocarcinoma-like elements. Immunohistochemically, the PSC components of all 7 cases were positive for vimentin and cytokeratins, including cytokeratin (CK) and cytokeratin 7 (CK7). Next-Generation Sequencing (NGS) was performed, and a total of 136 putative somatic variants and one gene fusion were identified, of which 16 variants were considered hot spot mutations, including the genes EGFR, EML4-ALK, MET, BRAF, PIK3CA, and TP53. Of these hot spot mutations, one sample expressing an EML4-ALK fusion was further confirmed by Ventana IHC, and one sample containing an EGFR exon 19 deletion was also confirmed. The NGS results imply that TP53 mutations occur often in PSCs and that EML4-ALK fusion events and EGFR exon deletions also occur in these rare tumors. Molecular targeted therapy may be a useful treatment strategy for these rare lung tumors.Xin LiDan WangQingchun ZhaoDian RenFan RenGang ChenHongyu LiuJun ChenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xin Li
Dan Wang
Qingchun Zhao
Dian Ren
Fan Ren
Gang Chen
Hongyu Liu
Jun Chen
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
description Abstract Pulmonary Sarcomatoid Carcinoma (PSC) constitutes a heterogeneous group of non-small-cell lung carcinomas (NSCLCs) with a poor prognosis. In this study, a group of 7 patients with PSC was studied. Microscope analysis of all 7 cases revealed a pleomorphic carcinoma subtype. Moreover, 5 cases (71.4%) were composed entirely of malignant sarcomatoid-like elements, and 2 cases (28.6%) were composed of malignant sarcomatoid-like elements and at least 10% adenocarcinoma-like elements. Immunohistochemically, the PSC components of all 7 cases were positive for vimentin and cytokeratins, including cytokeratin (CK) and cytokeratin 7 (CK7). Next-Generation Sequencing (NGS) was performed, and a total of 136 putative somatic variants and one gene fusion were identified, of which 16 variants were considered hot spot mutations, including the genes EGFR, EML4-ALK, MET, BRAF, PIK3CA, and TP53. Of these hot spot mutations, one sample expressing an EML4-ALK fusion was further confirmed by Ventana IHC, and one sample containing an EGFR exon 19 deletion was also confirmed. The NGS results imply that TP53 mutations occur often in PSCs and that EML4-ALK fusion events and EGFR exon deletions also occur in these rare tumors. Molecular targeted therapy may be a useful treatment strategy for these rare lung tumors.
format article
author Xin Li
Dan Wang
Qingchun Zhao
Dian Ren
Fan Ren
Gang Chen
Hongyu Liu
Jun Chen
author_facet Xin Li
Dan Wang
Qingchun Zhao
Dian Ren
Fan Ren
Gang Chen
Hongyu Liu
Jun Chen
author_sort Xin Li
title Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
title_short Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
title_full Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
title_fullStr Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
title_full_unstemmed Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma
title_sort clinical significance and next-generation sequencing of chinese pulmonary sarcomatoid carcinoma
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/7f255ce762154ad9ae0a37828e1def78
work_keys_str_mv AT xinli clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT danwang clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT qingchunzhao clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT dianren clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT fanren clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT gangchen clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT hongyuliu clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
AT junchen clinicalsignificanceandnextgenerationsequencingofchinesepulmonarysarcomatoidcarcinoma
_version_ 1718388900888576000